Contributors

A.M. James Shapiro first started experimenting with islet transplantation as a medical student at the University of Newcastle upon Thames. After multiple failures with mice and rats, he says his now famous Edmonton protocol was "really a last-ditch attempt" to make a good idea work in practice. Now director of the University of Alberta's Clinical Islet Transplant Program, Shapiro writes on page 43 about the "current state of the art of islet transplantation," for which a "combination of


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A.M. James Shapiro first started experimenting with islet transplantation as a medical student at the University of Newcastle upon Thames. After multiple failures with mice and rats, he says his now famous Edmonton protocol was "really a last-ditch attempt" to make a good idea work in practice. Now director of the University of Alberta's Clinical Islet Transplant Program, Shapiro writes on page 43 about the "current state of the art of islet transplantation," for which a "combination of hurdles" remains.

Fran Hawthorne, author of Merck Druggernaut (Wiley, 2003) has been covering healthcare and finance for more than 20 years for publications including the New York Times, Newsday, Fortune, and Business Week. On page 26, she tells the story of how Merck slipped from being "the gold standard" to "a synonym for the worst in the industry." Since the publication of her book three years ago, she says "things got even ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide